Ochsner Health Center

Batteryless Neurostimulator Shows Promising 6-Month Results for Overactive Bladder Treatment

• Neuspera's novel batteryless sacral neuromodulation system demonstrates 84% response rate in treating urgency urinary incontinence at 6-month follow-up. • The innovative device eliminates the need for a battery implant, requiring only a single incision for placement and utilizing external power transmission through a wearable disc. • Clinical outcomes match established efficacy benchmarks for traditional sacral neuromodulation therapy while offering a less invasive surgical approach.